Responses
Poster Presentation
Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials
Compose a Response to This Article
Other responses
No responses have been published for this article.
